1991
DOI: 10.1016/0166-3542(91)90071-x
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
1

Year Published

1992
1992
2016
2016

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 60 publications
(31 citation statements)
references
References 16 publications
1
29
1
Order By: Relevance
“…Since first described in early 1990s (24)(25)(26)(27)(28), amidate prodrugs of nucleotides have been the most successfully explored class of prodrugs to bypass the first phosphorylation step of nucleosides or to deliver nucleoside phosphonates into cells (29). TAF is the first nucleotide phosphonoamidate prodrug to successfully complete a proof-of-concept clinical efficacy study (30).…”
Section: Discussionmentioning
confidence: 99%
“…Since first described in early 1990s (24)(25)(26)(27)(28), amidate prodrugs of nucleotides have been the most successfully explored class of prodrugs to bypass the first phosphorylation step of nucleosides or to deliver nucleoside phosphonates into cells (29). TAF is the first nucleotide phosphonoamidate prodrug to successfully complete a proof-of-concept clinical efficacy study (30).…”
Section: Discussionmentioning
confidence: 99%
“…181 ppm) in the region expected for an alkyl phosphorodichloridite (Mark et aI., 1969). This material reacted cleanly with AZT in THF containing N-methyl imidazole; conditions that we have found most successful for the reaction of amino phosphorochloridates with nucleosides (McGuigan et a/., 1991). The presumed intermediate nucleoside alkyl phosphorochloridite was hydrolysed in situ to give the target compound (3a, Fig.…”
Section: Mementioning
confidence: 99%
“…The free 5'-monophosphate of AZT is of limited therapeutic interest on account of the poor membrane penetration by (charged) nucleotides (Cohen and Plunkett, 1975). Thus, much effort has gone into studies of masked nucleotides in an attempt to improve the therapeutic properties of the parent nucleoside analogues (Freed et al, 1989;Devine et al, 1990;McGuigan et al, 1990a;McGuigan et al, 1990b;McGuigan et al, 1990c;Henin et al, 1991;McGuigan et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…Given our experience in the improvement of the therapeutic performance of bio-active nucleosides by suitable phosphate modification [8,9,10,11,12] we wondered if a similar strategy might lead to enhancement of the properties of the parent ALP. *Corresponding author.…”
Section: Introductionmentioning
confidence: 99%